Cardio Diagnostics Holdings CDIO
NASDAQ CDIO
$2.03 -0.18 (-8.14%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cardio Diagnostics Holdings (CDIO) Amortizatization of Intangibles (2022 - 2026)

Cardio Diagnostics Holdings (CDIO) posted Amortizatization of Intangibles of $50412.0 for Q1 2026, up 1.11% sequentially from $49857.0 in Q4 2025, and down 42.49% YoY from $87664.0 in Q1 2025.

Cardio Diagnostics Holdings (CDIO) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Cardio Diagnostics Holdings has reported Amortizatization of Intangibles for 5 years, with the latest figure at $50412.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 42.49% year-over-year to $50412.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113076.0 (down 16.98% YoY) and the FY2025 annual result came in at $238065.0, up 46.44% from the prior year.
  • Amortizatization of Intangibles climbed to $50412.0 in Q1 2026 per CDIO's latest filing, from $49857.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $87664.0 in Q1 2025 and troughed at $794.0 in Q2 2024.
  • A 5-year average of $23403.1 and a median of $5655.0 in 2025 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles soared 1385.1% in 2023, then tumbled 97.94% in 2024.
  • Over 5 years, Amortizatization of Intangibles stood at $4000.0 in 2022, then jumped by 1385.1% to $59404.0 in 2023, then slipped by 20.99% to $46936.0 in 2024, then grew by 6.22% to $49857.0 in 2025, then climbed by 1.11% to $50412.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $50412.0, $49857.0, and $5655.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cardio Diagnostics Holdings 6.05 Mn 460,682.10 - 5,593.00

Historic Data

Download Data
DateValue
Jun 30, 2026 5,593.00
Jun 30, 2026 5,593.00
Mar 31, 2026 50,412.00
Mar 31, 2026 50,412.00
Dec 31, 2025 49,857.00
Dec 31, 2025 49,857.00
Sep 30, 2025 5,655.00
Sep 30, 2025 5,655.00
Jun 30, 2025 7,152.00
Jun 30, 2025 7,152.00
Mar 31, 2025 87,664.00
Mar 31, 2025 87,664.00
Dec 31, 2024 46,936.00
Dec 31, 2024 46,936.00
Sep 30, 2024 802.00
Sep 30, 2024 802.00
Jun 30, 2024 794.00
Jun 30, 2024 794.00
Mar 31, 2024 24,750.00
Mar 31, 2024 24,750.00